Intermap Appoints New Auditors

Stock Information for Crescita Therapeutics Inc.

Loading

Please wait while we load your information from QuoteMedia.

More Recent News About Crescita Therapeutics Inc.

Intermap Reports Third Quarter 2025 Results
Intermap Announces Date for Third Quarter Earnings
Intermap Technologies Closes Bought Deal Public Offering for Gross Proceeds of $28,752,300, Including the Full Exercise of the Over-Allotment Option
INTERMAP ANNOUNCES INCREASE TO BOUGHT DEAL FINANCING TO $25 MILLION
Intermap Technologies Files Final Short-Form Base Shelf Prospectus
Intermap Files Final Short-Form Base Shelf Prospectus
Intermap Reports Second Quarter 2025 Results
Intermap Announces Date for Second Quarter Earnings

Market data content copyright © QuoteMedia. Data delayed at least 15 minutes unless otherwise indicated (view Delay Times for all exchanges). Filings and Fundamentals by Morningstar. Insiders by Morningstar (USA) and SEDI (CDN). Analyst ratings by Zacks. Terms of Use.